The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters - Wikidata - awgldk - TriplyDB

The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters

The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters

http://www.wikidata.org/entity/Q33985842

about

Sleep disordered breathing, fatigue, and sleepiness in HIV-infected and -uninfected men Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients.Novel clinical trial designs for the development of new antiretroviral agents 18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy An update on the pharmacological strategies in the treatment of HIV-1-associated adipose redistribution syndromes.Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults.

P2860

Q33854860-DA13158D-D4B9-45DD-B4A6-B2F4382F0916 Q34596899-8DFE33AC-E9B2-427B-BEC0-393FF35C1324 Q35931303-164460CE-011C-4B8F-AF71-B0B795B6208F Q36311889-CB0EB803-6364-41E5-9F02-C2AB0606AB4D Q36853309-3055978D-7193-4FE5-887B-87F18DF0FE3E Q38220651-B3D70FF0-A45A-47D0-99FE-AD5AC9A02A50 Q41756147-1918C39B-EE0B-41A5-912C-783231071E6B

P2860

The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters

http://www.wikidata.org/entity/Q33985842

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The effects of intermittent, C ...... ition and metabolic parameters

@ast

The effects of intermittent, C ...... ition and metabolic parameters

@en

type

label

The effects of intermittent, C ...... ition and metabolic parameters

@ast

The effects of intermittent, C ...... ition and metabolic parameters

@en

prefLabel

The effects of intermittent, C ...... ition and metabolic parameters

@ast

The effects of intermittent, C ...... ition and metabolic parameters

@en

P1433

Q33985842-01B15156-1EE1-4D56-A571-44BC17390117

P1476

Q33985842-BF8E6D61-8990-421D-97B0-A94DC7236FA5

P2093

Q33985842-51340889-22D5-4E86-BB0A-9717A62115B5

Q33985842-52F358F1-096E-4DE2-9440-41D6347E9191

Q33985842-81D8C84F-F1C9-4C31-A183-FF8E8D8905E3

Q33985842-87EA5E08-B20D-4280-BA86-22FEFE1B23C7

Q33985842-90C29917-6DB2-4F47-ABF3-34BF413DA5A7

Q33985842-B8B74E4B-5ABC-4D4F-A62B-5F19A5C3697C

Q33985842-D3FD8B9C-7E2A-46B5-AC07-0C57F9CF7FA1

Q33985842-DCC86A2F-FA22-4BC5-AEC2-61F94EB1523F

Q33985842-E31F4669-9F1E-47DA-919C-13CD4A41698D

Q33985842-EA3145B5-CB61-4C76-83ED-C1D7D11CF2C2

P2860

Q33985842-04778D5F-E546-4079-A59A-FC0E18CD1E2A

Q33985842-04C0CDF8-2DC1-4AC0-A27C-CA3C98BCC731

Q33985842-08F326D7-1751-4BCE-AA61-35902E433EF1

Q33985842-0DAA2C92-BD96-4F84-BBD3-EA3D418CB306

Q33985842-1EBBE6A5-9070-4077-A019-810BF22060AF

Q33985842-2E31FC2D-9660-46C2-92FF-3FFC660E1DB3

Q33985842-3131D635-D7FD-4742-AC8F-324D2D045DF8

Q33985842-36C7A2FA-37A0-4AF0-AAC0-B4087EAB3B14

Q33985842-38F456AF-0EFA-4360-AC39-EF3ED6570382

Q33985842-49E0AAC4-1FFD-4C73-8759-11BA42EB687A

P304

Q33985842-4F75F77B-E07F-4BA2-8FD7-C1FB4911B9DB

P31

Q33985842-81CB1D22-E821-4E1B-BB84-2890750C4B54

P356

Q33985842-69E55B41-5FCC-41BC-94DD-AB2C8549AE2A

P407

Q33985842-6D9EAEBA-3395-4473-A919-383C6BA7E1FD

P433

Q33985842-FAFD9A2E-5D63-4167-B5D7-935FCF1D88B9

P478

Q33985842-39340095-77E4-40AD-86F7-03ECFB859313

P50

Q33985842-6337B940-D369-461F-9A9F-F45008CC90EE

P577

Q33985842-E99B798A-9227-4ED0-BD12-F7B588243228

P5875

Q33985842-6D934D34-0FD5-49E3-8203-EC4BCC09EB1A

P698

Q33985842-01C3906D-D16B-4C30-9541-49D955004DF7

P921

Q33985842-3F7CDB9F-E0F6-4682-B047-86F287C1D418

P932

Q33985842-2E987F8A-67F8-45BF-853A-E9E54836E44B

P356

QAD.0B013E3283333666

P1433

P1476

The effects of intermittent, C ...... ition and metabolic parameters

@en

P2093

Andrew Carr

http://www.w3.org/2001/XMLSchema#string

Avis Thomas

http://www.w3.org/2001/XMLSchema#string

Birgit Grund

http://www.w3.org/2001/XMLSchema#string

Cynthia Gibert

http://www.w3.org/2001/XMLSchema#string

Daniel Pearce

http://www.w3.org/2001/XMLSchema#string

Esteban Martinez

http://www.w3.org/2001/XMLSchema#string

Fehmida Visnegarwala

http://www.w3.org/2001/XMLSchema#string

Fraser Drummond

http://www.w3.org/2001/XMLSchema#string

INSIGHT SMART study group

http://www.w3.org/2001/XMLSchema#string

Judith Shlay

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

CD4+ count-guided interruption of antiretroviral treatment

Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort.

Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.

A1C underestimates glycemia in HIV infection

P304

353-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E3283333666

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40895254

http://www.w3.org/2001/XMLSchema#string

P698

20057309

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2902280

http://www.w3.org/2001/XMLSchema#string